Literature DB >> 6770268

Immunologic phenotype in 30 patients with diffuse large-cell lymphoma.

R Warnke, R Miller, T Grogan, M Pederson, J Dilley, R Levy.   

Abstract

Frozen sections of 30 diffuse large-cell ("histiocytic") lymphomas that had arisen in both nodal and extranodal sites were stained with immunoglobulin light-chain and heavy-chain reagents, with nonoclonal antibodies to THAT HAD ARISEN IN BOTH NODAL AND EXTRANODAL SITES WERE STAINED WITH IMMUNOGLOBULIN LIGHT-CHAIN AND HEAVY-CHAIN REAGENTS, WITH MONOCLONAL ANTIBODIES TO T and B-cell antigens, and with an esterase marker for macrophages. Fourteen lymphomas expressed immunoglobulin light chains and were shown to be monoclonal; F(ab')2 fragments were sometimes necessary to demonstrate their monoclonal nature. Mu (IgM) was the most frequently expressed heavy chain, but in many patients other heavy chains were found. None of the lymphomas stained with T-cell antibodies or the esterase; 15 did not stain for immunoglobulin, but 13 of these 15 did express Ia antigen. These immunologic markers identified eight different phenotypes. Retrospective clinical analysis of the patients suggested that those who were immunoglobulin-positive had more advanced disease and shorter survival, but confirmation of the clinical relevance of immunologic phenotype will require prospective studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6770268     DOI: 10.1056/NEJM198008073030601

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  29 in total

1.  Flow cytometric analysis of immunoglobulin heavy chain expression in B-cell lymphoma and reactive lymphoid hyperplasia.

Authors:  David D Grier; Samer Z Al-Quran; Diana M Cardona; Ying Li; Raul C Braylan
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.

Authors:  Heinz-Wolfram Bernd; Marita Ziepert; Christoph Thorns; Wolfram Klapper; Hans-Heinrich Wacker; Michael Hummel; Harald Stein; Martin-Leo Hansmann; German Ott; Andreas Rosenwald; Hans-Konrad Müller-Hermelink; Thomas F E Barth; Peter Möller; Sergio B Cogliatti; Michael Pfreundschuh; Norbert Schmitz; Lorenz Trümper; Silvia Höller; Markus Löffler; Alfred C Feller
Journal:  Haematologica       Date:  2009-11       Impact factor: 9.941

3.  Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.

Authors:  L M Weiss; G S Crabtree; R V Rouse; R A Warnke
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

4.  The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma.

Authors:  C M Spier; T M Grogan; S M Lippman; D J Slymen; J A Rybski; T P Miller
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

5.  Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.

Authors:  G Pallesen; P C Beverley; E B Lane; M Madsen; D Y Mason; H Stein
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

6.  Ultrastructural identification of neoplastic histiocytes--monocytes: an application of a newly developed cytochemical technique.

Authors:  H Kim; G A Pangalis; B C Payne; M E Kadin; H Rappaport
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

7.  The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients.

Authors:  R S Doggett; G S Wood; S Horning; R Levy; R F Dorfman; J Bindl; R A Warnke
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

8.  Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre.

Authors:  R Jansson; A Karlsson; U Forsum
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

9.  Malignant lymphomas: cell surface markers and advances in classification.

Authors:  J A Strauchen
Journal:  West J Med       Date:  1981-10

10.  Nucleolar organiser regions and survival in patients with non-Hodgkin's lymphomas classified by the working formulation.

Authors:  J Jakić-Razumović; D Tentor; M Petrovecki; I Radman
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.